DE4114325A1 - Octahydrobenzo(g)chinolin, seine herstellung und verwendung - Google Patents

Octahydrobenzo(g)chinolin, seine herstellung und verwendung

Info

Publication number
DE4114325A1
DE4114325A1 DE4114325A DE4114325A DE4114325A1 DE 4114325 A1 DE4114325 A1 DE 4114325A1 DE 4114325 A DE4114325 A DE 4114325A DE 4114325 A DE4114325 A DE 4114325A DE 4114325 A1 DE4114325 A1 DE 4114325A1
Authority
DE
Germany
Prior art keywords
compound
formula
acid addition
quinoline
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4114325A
Other languages
German (de)
English (en)
Inventor
Peter Dr Gull
Rudolf Dr Markstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Priority to DE4114325A priority Critical patent/DE4114325A1/de
Priority to HU9201296A priority patent/HUT61011A/hu
Priority to MYPI92000725A priority patent/MY131278A/en
Priority to EP92810306A priority patent/EP0512952A1/de
Priority to CS921311A priority patent/CS131192A3/cs
Priority to IL101735A priority patent/IL101735A0/xx
Priority to FI921957A priority patent/FI921957L/fi
Priority to CA002067648A priority patent/CA2067648A1/en
Priority to NZ242562A priority patent/NZ242562A/en
Priority to NO92921723A priority patent/NO921723L/no
Priority to AU15291/92A priority patent/AU656768B2/en
Priority to ZA923187A priority patent/ZA923187B/xx
Priority to KR1019920007312A priority patent/KR920021533A/ko
Priority to MX9202024A priority patent/MX9202024A/es
Priority to RO92-200596A priority patent/RO109333B1/ro
Priority to JP4112524A priority patent/JPH05170762A/ja
Priority to TW081103467A priority patent/TW241262B/zh
Priority to IE137492A priority patent/IE921374A1/en
Publication of DE4114325A1 publication Critical patent/DE4114325A1/de
Priority to US08/019,736 priority patent/US5262422A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE4114325A 1991-05-02 1991-05-02 Octahydrobenzo(g)chinolin, seine herstellung und verwendung Withdrawn DE4114325A1 (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DE4114325A DE4114325A1 (de) 1991-05-02 1991-05-02 Octahydrobenzo(g)chinolin, seine herstellung und verwendung
HU9201296A HUT61011A (en) 1991-05-02 1992-04-16 Process for producing octahydrobenzo/g/quinoline derivative and pharmaceutical compositions comprising same
MYPI92000725A MY131278A (en) 1991-05-02 1992-04-28 Octahydrobenzo [g] quinoline
EP92810306A EP0512952A1 (de) 1991-05-02 1992-04-28 Octahydrobenzo(g)chinolin
CS921311A CS131192A3 (en) 1991-05-02 1992-04-29 OCTAHYDROBENZO/g/QUINOLINE, PROCESS OF ITS PREPARATION AND APHARMACEUTICAL COMPOSITION CONTAINING SAID QUINOLINE
NO92921723A NO921723L (no) 1991-05-02 1992-04-30 Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
KR1019920007312A KR920021533A (ko) 1991-05-02 1992-04-30 옥타 하이드로 벤조[g] 퀴놀린
CA002067648A CA2067648A1 (en) 1991-05-02 1992-04-30 Octahydrobenzo[g]quinoline
NZ242562A NZ242562A (en) 1991-05-02 1992-04-30 An octahydro-3-[(2-pyridylthio)methyl]-1-methyl-6-hydroxy-benzo[g]quinoline derivative, preparation and pharmaceutical compositions
IL101735A IL101735A0 (en) 1991-05-02 1992-04-30 Octahydrobenzo(g)quinoline,its production and pharmaceutical compositions containing it
AU15291/92A AU656768B2 (en) 1991-05-02 1992-04-30 Octahydro-3-{(2-pyridylthio)methyl}-benzo{g}quinoline derivatives
ZA923187A ZA923187B (en) 1991-05-02 1992-04-30 Octahydrobenzo [G] quinoline
FI921957A FI921957L (fi) 1991-05-02 1992-04-30 Oktahydrobenzo(g)kinolin
MX9202024A MX9202024A (es) 1991-05-02 1992-04-30 Octa hidro benzo (g) quinolina y proceso para su produccion.
RO92-200596A RO109333B1 (ro) 1991-05-02 1992-04-30 Octahidrobenzo/g/chinolina si procedeu pentru preparea acesteia
JP4112524A JPH05170762A (ja) 1991-05-02 1992-05-01 オクタヒドロベンゾ［ｇキノリン
TW081103467A TW241262B (enExample) 1991-05-02 1992-05-04
IE137492A IE921374A1 (en) 1991-05-02 1992-07-01 Octahydrobenzo[g]quinoline
US08/019,736 US5262422A (en) 1991-05-02 1993-02-19 Octahydrobenzo[g]quinoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4114325A DE4114325A1 (de) 1991-05-02 1991-05-02 Octahydrobenzo(g)chinolin, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
DE4114325A1 true DE4114325A1 (de) 1992-11-05

Family

ID=6430818

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4114325A Withdrawn DE4114325A1 (de) 1991-05-02 1991-05-02 Octahydrobenzo(g)chinolin, seine herstellung und verwendung

Country Status (18)

Country Link
EP (1) EP0512952A1 (enExample)
JP (1) JPH05170762A (enExample)
KR (1) KR920021533A (enExample)
AU (1) AU656768B2 (enExample)
CA (1) CA2067648A1 (enExample)
CS (1) CS131192A3 (enExample)
DE (1) DE4114325A1 (enExample)
FI (1) FI921957L (enExample)
HU (1) HUT61011A (enExample)
IE (1) IE921374A1 (enExample)
IL (1) IL101735A0 (enExample)
MX (1) MX9202024A (enExample)
MY (1) MY131278A (enExample)
NO (1) NO921723L (enExample)
NZ (1) NZ242562A (enExample)
RO (1) RO109333B1 (enExample)
TW (1) TW241262B (enExample)
ZA (1) ZA923187B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659430A1 (en) * 1993-12-21 1995-06-28 Sandoz Ltd. Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
USRE42802E1 (en) 2000-04-18 2011-10-04 H. Lundbeck A/S Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE56958T1 (de) * 1981-10-16 1990-10-15 Sandoz Ag 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolinderivate mit pharmazeutischer wirkung.
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659430A1 (en) * 1993-12-21 1995-06-28 Sandoz Ltd. Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
USRE42802E1 (en) 2000-04-18 2011-10-04 H. Lundbeck A/S Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
USRE43244E1 (en) 2000-04-18 2012-03-13 H. Lundbeck A/S Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use

Also Published As

Publication number Publication date
CA2067648A1 (en) 1992-11-03
FI921957A7 (fi) 1992-11-03
FI921957L (fi) 1992-11-03
IE921374A1 (en) 1992-11-04
NZ242562A (en) 1994-08-26
FI921957A0 (fi) 1992-04-30
HUT61011A (en) 1992-11-30
CS131192A3 (en) 1992-11-18
KR920021533A (ko) 1992-12-18
MX9202024A (es) 1992-11-01
NO921723L (no) 1992-11-03
NO921723D0 (no) 1992-04-30
TW241262B (enExample) 1995-02-21
ZA923187B (en) 1993-11-01
MY131278A (en) 2007-07-31
JPH05170762A (ja) 1993-07-09
IL101735A0 (en) 1992-12-30
AU1529192A (en) 1992-11-05
RO109333B1 (ro) 1995-01-30
EP0512952A1 (de) 1992-11-11
AU656768B2 (en) 1995-02-16
HU9201296D0 (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DE60030883T2 (de) Verfahren zur herstellung von alfentanil, sufentanil und remifentanil
EP0153277B1 (de) Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
CH621115A5 (enExample)
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
EP0271795A2 (de) Octahydro-10-oxo-6H-pyridazo [1,2-a] [1,2] diazepin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2305092C2 (enExample)
DE3149010A1 (de) (+)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3- diazacyclopent-2-en, dessen herstellung und seine verwendung in pharamazeutischen praeparaten
DE1795022C3 (de) Lysergsäurederivate
DE60311233T2 (de) Chinolinderivate
DE3326724A1 (de) In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE2659932C2 (de) Racemischer 3-Hydroxymethylen-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
DE4117750A1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4114325A1 (de) Octahydrobenzo(g)chinolin, seine herstellung und verwendung
DE2749584A1 (de) Ueberbrueckte geminale diphenylpiperidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0002672A2 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3320028C2 (enExample)
DE69515402T2 (de) Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
DE69709869T2 (de) BENZO[g]CHINOLIN DERIVATE
US5262422A (en) Octahydrobenzo[g]quinoline
DE2714148C3 (de) 1-(Naphthylmethyl)-4-thiazolylpipirazine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE69300011T2 (de) Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DD253616A5 (de) Verfahren zur herstellung von neuen pleunromutilinderivaten
CH619237A5 (enExample)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee